DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @AmericanBanking | 9 |
| @prosperousguy | 6 |
| @1MinuteStock | 6 |
| @TranscriptDaily | 5 |
| @slick_trader24 | 5 |
Recent Tweets for EXEL
 |
@AmericanBanking Exelixis, Inc. $EXEL Expected to Announce Quarterly Sales of $231.61 Million https://t.co/UkvRGDvQiq #stocks November 10th 2019, 9:11am |
 |
@BlueBioNow $EXEL significant price movement on this stock 4.09 % change recently https://t.co/eWEVF0GCau November 9th 2019, 8:11pm |
 |
@bbnsnews Exelixis, Inc. $EXEL Receives $24.71 Consensus Target Price from Brokerages https://t.co/4NZQemSz9p November 9th 2019, 5:11pm |
 |
@ConsumerFeed Exelixis, Inc. $EXEL Receives $24.71 Average Price Target from Brokerages https://t.co/aISfgKXk3v November 9th 2019, 5:11pm |
 |
@Gambiste1 RT @biotechw2019: $EXEL want to stabilize at gap filled and 3 years support of indecision triangle. a break down here and the target is $12… November 9th 2019, 1:11pm |
 |
@prosperousguy @semodough Hey Dough, $EXEL Bull here, can you list more of the events/catalysts for $EXEL that are coming up? TIA November 9th 2019, 12:11pm |
|
@prosperousguy @rosderek @newsfilterio Any links to upcoming $EXEL events/catalysts? Love to see that TIA November 9th 2019, 12:11pm |
 |
@biotechw2019 $EXEL want to stabilize at gap filled and 3 years support of indecision triangle. a break down here and the target… https://t.co/cn1Bhcn0AB November 9th 2019, 11:11am |
 |
@rosderek @prosperousguy @newsfilterio Appreciate your inputs on $exel, IMO don’t see a BO, especially at $27, mgmt thinks Ca… https://t.co/CSV7NcGnc1 November 9th 2019, 11:11am |
|
@prosperousguy @newsfilterio I want to be able to say that, THAT sale was the worst ever by a supposed 'insider" as $EXEL pops $11… https://t.co/fltnTIOaL9 November 9th 2019, 11:11am |
 |
@ThisLincolnian Exelixis, Inc. $EXEL CMO Gisela Schwab Sells 50,000 Shares https://t.co/8OS7LsV0VN November 9th 2019, 5:11am |
 |
@WeekHerald Exelixis, Inc. $EXEL CMO Sells $799,500.00 in Stock https://t.co/80r4FZKG3d November 9th 2019, 4:11am |
 |
@endpts Eyeing second Japanese approval, #Daiichi and Exelixis announce positive pivotal for kidney drug https://t.co/IqS9aZvzEs $EXEL November 8th 2019, 7:11pm |
 |
@gcassidy718 $EXEL sizable quote changes 2.67 % change recently https://t.co/yJURATPF4w November 8th 2019, 4:11pm |
 |
@slick_trader24 $EXEL weekly chart https://t.co/sSmuPAFMCQ November 8th 2019, 2:11pm |
 |
@Briefingcom $EXEL: Exelixis collaborator Daiichi Sankyo reports positive results from Phase 3 pivotal trial of Esaxerenone https://t.co/sJ9Gy3boMJ November 8th 2019, 8:11am |
 |
@stocknewstimes Exelixis $EXEL Stock Rating Upgraded by ValuEngine https://t.co/lr4NzP3NWz November 8th 2019, 8:11am |
 |
@newsfilterio $524,000.00 of shares sold by Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) $EXEL https://t.co/Z5rYoUTw4R November 8th 2019, 5:11am |
|
@AmericanBanking Zacks: Brokerages Expect Exelixis, Inc. $EXEL Will Announce Earnings of $0.15 Per Share https://t.co/8Ch4MCNqIu #stocks November 8th 2019, 5:11am |
 |
@OlympiaReport Zacks: Brokerages Expect Exelixis, Inc. $EXEL Will Announce Earnings of $0.15 Per Share https://t.co/Y56LH9tp8v November 8th 2019, 5:11am |
 |
@dispatchtribune Zacks: Brokerages Expect Exelixis, Inc. $EXEL Will Announce Earnings of $0.15 Per Share https://t.co/VFaeurwu3Z November 8th 2019, 5:11am |
|
@Gambiste1 RT @slick_trader24: $EXEL gap filled and now some good news released tonight November 7th 2019, 9:11pm |
|
@slick_trader24 $EXEL gap filled and now some good news released tonight November 7th 2019, 8:11pm |
 |
@ZolmaxNews Exelixis, Inc. $EXEL Receives $24.71 Consensus Target Price from Brokerages https://t.co/IkOGXP84mQ November 7th 2019, 4:11pm |
|
@dispatchtribune Exelixis, Inc. $EXEL CMO Gisela Schwab Sells 50,000 Shares https://t.co/ft3YSauy4w November 7th 2019, 10:11am |
|
@OlympiaReport Exelixis, Inc. $EXEL CMO Sells $799,500.00 in Stock https://t.co/xkpxDhXf0z November 7th 2019, 10:11am |
 |
@insiderbuyings $EXEL new insider selling: 50000 shares. https://t.co/xjRrt8STVo November 6th 2019, 11:11pm |
|
@AmericanBanking Insider Selling: Exelixis, Inc. $EXEL CMO Sells 50,000 Shares of Stock https://t.co/ZGV7NfFlTn #stocks November 6th 2019, 9:11pm |
 |
@WatchlistN Insider Selling: Exelixis, Inc. $EXEL CMO Sells 50,000 Shares of Stock https://t.co/nxSZSlBTNC November 6th 2019, 9:11pm |
 |
@TickerReport Insider Selling: Exelixis, Inc. $EXEL CMO Sells 50,000 Shares of Stock https://t.co/HTfCfPaw14 November 6th 2019, 9:11pm |
 |
@dailypoliticaln Gisela Schwab Sells 50,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/4LyFXT4Ye2 November 6th 2019, 9:11pm |
 |
@InsiderAlertsIA $EXEL: New Insider Filing on Pres, Prod Dev & Med Aff & CMO GISELA SCHWAB: https://t.co/nsGshDTwou November 6th 2019, 8:11pm |
 |
@MonitorAction $EXEL Gisela Schwab Dumps 50K Shares of EXELIXIS, INC. https://t.co/pnjfaC4rgT November 6th 2019, 8:11pm |
 |
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/ICV7NdCmwl November 6th 2019, 8:11pm |
|
@slick_trader24 $EXEL there’s the flush to gap https://t.co/uMTkiw7TEu November 6th 2019, 4:11pm |
|
@dailypoliticaln Exelixis $EXEL Raised to Sell at ValuEngine https://t.co/rtpGG2qQiQ November 6th 2019, 8:11am |
 |
@TranscriptDaily Q4 2019 Earnings Estimate for Exelixis, Inc. Issued By Oppenheimer $EXEL https://t.co/YRlQpXLMfK November 6th 2019, 3:11am |
|
@stocknewstimes Q4 2019 Earnings Estimate for Exelixis, Inc. Issued By Oppenheimer $EXEL https://t.co/stTchEaZaR November 6th 2019, 3:11am |
|
@OlympiaReport Piper Jaffray Companies Weighs in on Exelixis, Inc.’s Q4 2019 Earnings $EXEL https://t.co/cYeKPPVLb2 November 6th 2019, 3:11am |
|
@WeekHerald Piper Jaffray Companies Weighs in on Exelixis, Inc.’s Q4 2019 Earnings $EXEL https://t.co/waoICulYfi November 6th 2019, 3:11am |
|
@TickerReport Exelixis $EXEL Upgraded to Sell by ValuEngine https://t.co/PUy9ENFpgr November 5th 2019, 10:11pm |
|
@ZolmaxNews Exelixis $EXEL Upgraded to Sell by ValuEngine https://t.co/hn5UdsoSwl November 5th 2019, 10:11pm |
|
@TranscriptDaily Piper Jaffray Companies Analysts Cut Earnings Estimates for Exelixis, Inc. $EXEL https://t.co/ATGGpAVjwt November 5th 2019, 3:11am |
 |
@TheMarketsDaily Exelixis, Inc. $EXEL Expected to Post Q4 2019 Earnings of $0.10 Per Share https://t.co/4XFsOV3VFy November 5th 2019, 3:11am |
|
@stocknewstimes Piper Jaffray Companies Analysts Cut Earnings Estimates for Exelixis, Inc. $EXEL https://t.co/1QR2XOBsSf November 5th 2019, 3:11am |
|
@biotechw2019 $EXEL appears the weekly support trend line is holding. watching for a follow through week after the support touche… https://t.co/O53iQLdJNS November 4th 2019, 7:11am |
|
@AmericanBanking Exelixis, Inc. $EXEL Receives Consensus Recommendation of “Hold” from Analysts https://t.co/5XIO2PuGTI #stocks November 4th 2019, 5:11am |
|
@TranscriptDaily Exelixis, Inc. $EXEL Receives Consensus Recommendation of “Hold” from Analysts https://t.co/442Sk2QeNI November 4th 2019, 5:11am |
 |
@EnterpriseLeade Exelixis, Inc. $EXEL Given Average Rating of “Hold” by Analysts https://t.co/QZELbodMjw November 4th 2019, 5:11am |
|
@AmericanBanking Exelixis, Inc. Forecasted to Earn Q4 2019 Earnings of $0.15 Per Share $EXEL https://t.co/dckKlQAp7C #stocks November 4th 2019, 3:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.